Cargando…
HEPA and PARSE: Systematic discovery of clinically relevant tumor-specific antigens
The effective discovery of tumor-specific antigens (TSAs) holds the key for the development of new diagnostic assays and immunotherapeutic approaches against cancer. Here, we discuss our recently developed technologies, HEPA and PARSE, which allow for the systematic identification of TSAs, generatin...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Landes Bioscience
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661158/ https://www.ncbi.nlm.nih.gov/pubmed/23802073 http://dx.doi.org/10.4161/onci.23249 |